Mental health conditions up in public health workers during pandemic
Jun 28, 2021
53.0 percent in public health departments reported symptoms of at least one condition in survey conducted during March, April 2021
Clinical briefs for Friday, May 19
By
Alicia Lasek
May 19, 2023
‘Medical freedom’ measures ban mask and vaccine mandates … Genetic links for hypertension, high cholesterol and Alzheimer’s may support new drug targets … WHO advisers say COVID-19 vaccines should...
Working night shift may increase risk for atrial fibrillation
Aug 30, 2021
Risk increased for both current and long-term exposure to night shift work regardless of genetic risk for atrial fibrillation
British health official: Cure for dementia could come by 2020
By
Ashley Carman
Jul 11, 2013
Advances in genetics and pharmaceuticals could lead to a cure for dementia by 2020, according to United Kingdom Secretary of Health Jeremy Hunt.
Pharma company expands in Tennessee
May 03, 2017
Aphena Pharma Solutions announced it has expanded its solid-dose packaging operations in Cookeville, TN. The expansion doubled the size of the facility, increasing manufacturing and warehouse space, and...
Researchers: Alzheimer’s might start in the liver
Mar 07, 2011
The brain “plaques” commonly associated with Alzheimer’s disease might actually originate in the liver, according to a startling new discovery by scientists at Scripps Research Institute.
Mayo Clinic receives patent for GeneSight
May 22, 2013
The Mayo Clinic has received a patent for a new medication selection procedure. GeneSight uses a test to prioritize the selection of medications for patients with depression, chronic pain and other psychiatric...
Clinical briefs for Tuesday, May 16
By
Alicia Lasek
May 15, 2023
Exercise significantly improves quality of life for assisted living residents, studies find … FDA updates boxed warning on all stimulants, citing misuse … Older adults derived more protection from...
CMS: New rule to save Medicaid billions in drug payments
By
Haymarket Media
Jul 10, 2007
A new rule designed to stop the federal government from making inflated drug reimbursements to state agencies will save billions of dollars, the Centers for Medicare & Medicaid Services announced recently.
Medicaid costs for antipsychotics to decrease as patents expire
By
Aug 26, 2015
Expiring patents for blockbuster antipsychotic medications is expected to increase use of the drugs’ generic versions and save Medicaid billions of dollars annually, a new study shows.